Pharmaceutical - Mergers & Acquisitions, Management

Filter

Popular Filters

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

23-08-2014

Pershing Square Capital Management, the largest shareholder of Allergan, which is the subject of a $53…

AllerganManagementMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

SillaJen changes its name to mark Jennerex acquisition

20-06-2014

South Korean privately held pharma company SillaJen has changed its name to SillaJen Biotherapeutics…

Asia-PacificJennerexManagementMergers & AcquisitionsOncologyPexa-VecPharmaceuticalSillaJen

Baxter to split, creating two separate health care companies

Baxter to split, creating two separate health care companies

28-03-2014

News that USA-based Baxter International plans to create two separate, independent global health care…

Baxter InternationalManagementMergers & AcquisitionsPharmaceutical

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

Are you overlooking the “X Factor” in Biopharma M&A? asks JLL expert

12-03-2014

When Merck & Co acquired Schering-Plough in 2009, the corporate real estate team reduced the combined…

ManagementMerck & CoMergers & AcquisitionsPharmaceutical

Pfizer to separate business into three units: will this lead to spin-outs?

29-07-2013

Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Endo Health to slash workforce, view options for HealthTronics and branded pharma unit

07-06-2013

USA-based Endo Health Solutions (Nasdaq: ENDP) has outlined the strategic, operational and organizational…

FinancialManagementMergers & AcquisitionsPharmaceutical

Theravance to split into two, halting speculation of a full takeover by GSK

29-04-2013

US drug developer Theravance (Nasdaq: THRX) has announced its intention to create two independent publicly…

Anoro ElliptaBiotechnologyBreo ElliptaGlaxoSmithKlineManagementMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoyalty Management CoTheravanceTheravance Biopharma

AstraZeneca management shakeup sign of major restructuring leading to stock recovery, say analysts

17-01-2013

The management changes at Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this week do not…

AstraZenecaBrilintaBriliqueFinancialManagementMergers & AcquisitionsPharmaceuticalShire

Japan's vulnerable pharma companies, by P Reed Maurer

12-09-2012

Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Parexel

Parexel

Back to top